Genentech/Xoma Raptiva Clears FDA, Priced At 25% Discount to Amevive

Genentech/Xoma's psoriasis therapy Raptiva will be available by Thanksgiving at a 25% discount to a full year of Biogen's intramuscular injection formulation of Amevive

More from Archive

More from Pink Sheet